Cancer Biomarkers

cancer growth development biomarker implies a substance or method that is definite of the proximity of infection in the body. A biomarker may be an iota released by a cancer or a specific response of the body to the closeness of harm. Inherited, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer growth development assurance, perception, and the investigation of infection transmission. Such biomarkers is tried in non-prominently accumulated bio liquids like blood or fluid body substance.

Various quality and protein based biomarkers have recently been used in the end in open minded thought; including,

  • AFP (Liver Cancer)
  • BCR-ABL (Chronic Myeloid Leukemia)
  • BRCA1/BRCA2 (Breast/Ovarian Cancer)
  • BRAF V600E (Melanoma/Colorectal Cancer)

    Related Conference of Cancer Biomarkers

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in